Evaluating the Predictive Capability of Transcriptomic Profiling for Identifying the Primary Site of Metastatic Tumors
NCT07319949
CUP, Malignant Tumor With Metastasis
View Trial DetailsNCT Number: NCT07616011
Early detection and timely intervention of distant metastasis are essential for improving the prognosis of patients with malignant tumors. However, current clinical methods have notable limitations. Conventional imaging can only detect macroscopic metastatic lesions, failing to seize the optimal intervention window before metastasis occurs or during the micrometastasis stage. Previous research has adopted artificial intelligence to break the constraints of traditional imaging and realized subclinical early warning of distant metastasis based on retrospective data. On this basis, the present study aims to systematically validate the predictive performance and generalizability of the model in real-world clinical settings via a prospective cohort. This study intends to establish an organ-specific, non-invasive and cost-effective pan-cancer tool for early warning of distant metastasis. It can gain critical time for clinical intervention, help reduce the incidence of distant metastasis and ultimately optimize patient prognosis.
Trial opening soon.
Get Notified18 year–95 year
All sexes
Observational
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: At each routine follow-up visit (interval: approximately 6 months to 1 year)
Proportion of patients with distant metastasis among malignant tumor cases
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07319949
CUP, Malignant Tumor With Metastasis
View Trial Details